Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
MET	Splice_Site		G	G		1	Investigate Actionability	7	116435940	116435940	422	0.471563981042654	NA	NA	NA			233		Amplification may cause resistance to anti-EGFR TKIs.  Amplification may predict sensitivity to MET-inhibitors	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MET&recr=Open">Click here</a>	
PTEN	Missense_Mutation	p.G129E	G	G	rs121909218	1	Investigate Actionability	10	89692902	89692902	283	0.551236749116608	NA	NA	NA		p.0?(37)|p.?(5)|p.R55fs*1(5)|p.G129V(3)|p.K128_R130del(3)|p.G129E(2)|p.Y27fs*1(2)|p.A121_F145del(1)|p.G127fs*5(1)|p.F56fs*2(1)|p.K128fs*47(1)	2771	Phosphatase tensin-type. {ECO:0000255|PROSITE-ProRule:PRU00590}.	Biallelic inactivation may predict sensitivity to PI3K pathway inhibitors -- PI3K inhibitors, AKT inhibitors, and MTOR inhibitors.  Biallelic inactivation may predict resistance to anti-RTK therapy, including cetuximab, anti-EGFR TKIs, and trastuzumab and lapatinib.  Biallelic inactivation may predict sensitivity to PARP inhibitors	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTEN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,89692902,G,G&fts=all">p.G129E</a>
BRAF	In_Frame_Del	p.600_601VK>E	TCA	TCA	rs121913377|rs121913226|rs113488022|rs121913364|rs121913227|rs397516897	1.75	High Priority	7	140453134	140453136	546	0.582417582417582	NA	NA	NA		p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.K601E(40)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.K601del(1)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.V600V(1)|p.T599_V600insDFGLAT(1)	27380	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations predict sensitivity to RAF inhibitors. Amplification may predict resistance to MEK inhibitors.	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRAF&recr=Open">Click here</a>	
BRD2	Missense_Mutation	p.K402N	G	G		2	High Priority	6	32945224	32945224	454	0.0220264317180617	NA	NA	NA			5	Bromo 2. {ECO:0000255|PROSITE- ProRule:PRU00035}.	Alterations may preict sensitivity to HDAC inhibitors, bromodomain inhibitors	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32945224,G,G&fts=all">p.K402N</a>
MSH6	Missense_Mutation	p.S314G	A	A		2	High Priority	2	48026062	48026062	582	0.00859106529209622	NA	NA	NA		p.0?(2)	229		Prognostic / Diagnostic in colon cancer	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,48026062,A,A&fts=all">p.S314G</a>
ROS1	Missense_Mutation	p.K2N	C	C		2	High Priority	6	117746814	117746814	328	0.347560975609756	NA	NA	NA			162		Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117746814,C,C&fts=all">p.K2N</a>
LCK	Missense_Mutation	p.G85R	G	G		4	Cancer Gene Census	1	32740659	32740659	233	0.343347639484979	NA	NA	NA			37	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,32740659,G,G&fts=all">p.G85R</a>
MLLT4	Missense_Mutation	p.G543E	G	G		4	Cancer Gene Census	6	168303044	168303044	331	0.329305135951662	NA	NA	NA			65			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,168303044,G,G&fts=all">p.G543E</a>
MYD88	Missense_Mutation	p.P166S	C	C		4	Cancer Gene Census	3	38181483	38181483	52	0.25	NA	NA	NA			237	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYD88&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38181483,C,C&fts=all">p.P166S</a>
TNN	Splice_Site	p.D707N	G	G		4.25	Cancer Pathway Linked to: MSH6; BRAF	1	175067731	175067731	118	0.288135593220339	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	
ALB	Missense_Mutation	p.L29F	C	C		4.5	Cancer Pathway Linked to: BRAF	4	74275124	74275124	369	0.319783197831978	NA	NA	NA	 KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		48			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74275124,C,C&fts=all">p.L29F</a>
HFM1	Missense_Mutation	p.P973L	G	G		5	Cancer Pathway	1	91781722	91781722	227	0.215859030837004	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75	SEC63.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91781722,G,G&fts=all">p.P973L</a>
HFM1	Missense_Mutation	p.P973S	G	G		5	Cancer Pathway	1	91781723	91781723	225	0.217777777777778	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		75	SEC63.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,91781723,G,G&fts=all">p.P973S</a>
ITGB7	Missense_Mutation	p.K24N	C	C		5	Cancer Pathway	12	53594156	53594156	175	0.285714285714286	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53594156,C,C&fts=all">p.K24N</a>
PPIL2	Missense_Mutation	p.A492T	G	G		6	Cancer Pathway	22	22049690	22049690	45	0.266666666666667	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		17			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPIL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,22049690,G,G&fts=all">p.A492T</a>
PHKG1	Missense_Mutation	p.L144P	A	A		6.75	Cancer Module	7	56151087	56151087	300	0.463333333333333	NA	NA	NA			7	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHKG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,56151087,A,A&fts=all">p.L144P</a>
ABAT	Missense_Mutation	p.P66S	C	C		7	Cancer Module	16	8839938	8839938	176	0.301136363636364	NA	NA	NA			26			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,8839938,C,C&fts=all">p.P66S</a>
AGTR1	Missense_Mutation	p.G45E	G	G		7	Cancer Module	3	148458956	148458956	195	0.251282051282051	NA	NA	NA		p.G45A(1)	30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGTR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,148458956,G,G&fts=all">p.G45E</a>
ANGPTL4	Missense_Mutation	p.H154N	C	C		7	Cancer Module	19	8431116	8431116	180	0.0222222222222222	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANGPTL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8431116,C,C&fts=all">p.H154N</a>
ANKFY1	Missense_Mutation	p.G918S	C	C		7	Cancer Module	17	4080447	4080447	188	0.319148936170213	NA	NA	NA			32			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKFY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4080447,C,C&fts=all">p.G918S</a>
APOB	Missense_Mutation	p.D2486N	C	C		7	Cancer Module	2	21232284	21232284	427	0.320843091334895	NA	NA	NA			305			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21232284,C,C&fts=all">p.D2486N</a>
ARHGEF5	Missense_Mutation	p.P1562S	C	C		7	Cancer Module	7	144077039	144077039	552	0.159420289855072	NA	NA	NA			40	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,144077039,C,C&fts=all">p.P1562S</a>
ATP2B2	Missense_Mutation	p.R732Q	C	C		7	Cancer Module	3	10391870	10391870	89	0.224719101123595	NA	NA	NA			74			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,10391870,C,C&fts=all">p.R732Q</a>
ATP5F1	Missense_Mutation	p.R55C	C	C		7	Cancer Module	1	111996918	111996918	453	0.33112582781457	NA	NA	NA		p.R55C(1)	8			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP5F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,111996918,C,C&fts=all">p.R55C</a>
BDNF	Missense_Mutation	p.A150V	G	G		7	Cancer Module	11	27679663	27679663	385	0.374025974025974	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BDNF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,27679663,G,G&fts=all">p.A150V</a>
BLNK	Missense_Mutation	p.E233K	C	C		7	Cancer Module	10	97969643	97969643	168	0.464285714285714	NA	NA	NA			14	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLNK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,97969643,C,C&fts=all">p.E233K</a>
CACNA1A	Missense_Mutation	p.E137K	C	C		7	Cancer Module	19	13563820	13563820	203	0.275862068965517	NA	NA	NA			42			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13563820,C,C&fts=all">p.E137K</a>
CAPS2	Splice_Site	p.A293V	G	G		7	Cancer Module	12	75676126	75676126	565	0.27787610619469	NA	NA	NA			10			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPS2&recr=Open">Click here</a>	
CASP14	Missense_Mutation	p.M52I	G	G		7	Cancer Module	19	15164421	15164421	265	0.316981132075472	NA	NA	NA			26			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASP14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15164421,G,G&fts=all">p.M52I</a>
CCDC69	Missense_Mutation	p.E70K	C	C		7	Cancer Module	5	150581166	150581166	125	0.416	NA	NA	NA			9			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC69&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,150581166,C,C&fts=all">p.E70K</a>
CEP192	Missense_Mutation	p.S2197F	C	C		7	Cancer Module	18	13099507	13099507	303	0.297029702970297	NA	NA	NA			71			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP192&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,13099507,C,C&fts=all">p.S2197F</a>
COL12A1	Missense_Mutation	p.G2798R	C	C		7	Cancer Module	6	75812336	75812336	132	0.348484848484849	NA	NA	NA			169	Collagen-like 1.|Triple-helical region (COL2) with 1 imperfection.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL12A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,75812336,C,C&fts=all">p.G2798R</a>
CP	Missense_Mutation	p.G27E	C	C		7	Cancer Module	3	148939500	148939500	314	0.328025477707006	NA	NA	NA			44	F5/8 type A 1.|Plastocyanin-like 1.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,148939500,C,C&fts=all">p.G27E</a>
CRYM	Missense_Mutation	p.S160F	G	G		7	Cancer Module	16	21281121	21281121	212	0.367924528301887	NA	NA	NA			4			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,21281121,G,G&fts=all">p.S160F</a>
CYP39A1	Missense_Mutation	p.S88F	G	G		7	Cancer Module	6	46609950	46609950	119	0.352941176470588	NA	NA	NA			21			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP39A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,46609950,G,G&fts=all">p.S88F</a>
DPP4	Missense_Mutation	p.S284F	G	G		7	Cancer Module	2	162890087	162890087	272	0.3125	NA	NA	NA			48			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,162890087,G,G&fts=all">p.S284F</a>
DPYD	Missense_Mutation	p.P374S	G	G	rs201785202	7	Cancer Module	1	98058782	98058782	329	0.31306990881459	NA	NA	NA			83			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,98058782,G,G&fts=all">p.P374S</a>
FARP2	Missense_Mutation	p.P391S	C	C	rs534611220	7	Cancer Module	2	242380731	242380731	336	0.330357142857143	NA	NA	NA			43			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FARP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242380731,C,C&fts=all">p.P391S</a>
FERMT2	Missense_Mutation	p.L73P	A	A		7	Cancer Module	14	53386014	53386014	438	0.319634703196347	NA	NA	NA			20	Interaction with membranes containing phosphatidylinositol phosphate.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERMT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,53386014,A,A&fts=all">p.L73P</a>
GALNT13	Missense_Mutation	p.R194Q	G	G	rs374003992	7	Cancer Module	2	155099313	155099313	174	0.310344827586207	NA	NA	NA		p.R194Q(1)	65	Catalytic subdomain A.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155099313,G,G&fts=all">p.R194Q</a>
GAS6	Missense_Mutation	p.D199H	C	C		7	Cancer Module	13	114538603	114538603	204	0.102941176470588	NA	NA	NA			5	EGF-like 3; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,114538603,C,C&fts=all">p.D199H</a>
GPR126	Missense_Mutation	p.G494E	G	G		7	Cancer Module	6	142718806	142718806	121	0.363636363636364	NA	NA	NA			36			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR126&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,142718806,G,G&fts=all">p.G494E</a>
GREB1	Missense_Mutation	p.P1799S	C	C		7	Cancer Module	2	11777890	11777890	156	0.333333333333333	NA	NA	NA			30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GREB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,11777890,C,C&fts=all">p.P1799S</a>
GRM8	Missense_Mutation	p.D743N	C	C		7	Cancer Module	7	126173209	126173209	136	0.242647058823529	NA	NA	NA			125			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,126173209,C,C&fts=all">p.D743N</a>
HS1BP3	Missense_Mutation	p.E107K	C	C		7	Cancer Module	2	20840820	20840820	361	0.332409972299169	NA	NA	NA			15	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS1BP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,20840820,C,C&fts=all">p.E107K</a>
HSPG2	Missense_Mutation	p.Q2645P	T	T		7	Cancer Module	1	22174273	22174273	52	0.230769230769231	NA	NA	NA			127	Ig-like C2-type 12.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,22174273,T,T&fts=all">p.Q2645P</a>
IL5RA	Missense_Mutation	p.E26K	C	C		7	Cancer Module	3	3146593	3146593	270	0.281481481481481	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL5RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,3146593,C,C&fts=all">p.E26K</a>
ISLR	Missense_Mutation	p.D140N	G	G		7	Cancer Module	15	74467617	74467617	110	0.372727272727273	NA	NA	NA			20			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ISLR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74467617,G,G&fts=all">p.D140N</a>
KIF5C	Missense_Mutation	p.D684N	G	G		7	Cancer Module	2	149853804	149853804	111	0.324324324324324	NA	NA	NA			36			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF5C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,149853804,G,G&fts=all">p.D684N</a>
KLHL13	Missense_Mutation	p.G353E	C	C		7	Cancer Module	X	117043419	117043419	124	0.766129032258065	NA	NA	NA		p.G404E(1)	34			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,117043419,C,C&fts=all">p.G353E</a>
LRRC49	Missense_Mutation	p.S268F	C	C		7	Cancer Module	15	71305234	71305234	294	0.346938775510204	NA	NA	NA			34			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC49&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,71305234,C,C&fts=all">p.S268F</a>
LTBP1	Nonsense_Mutation	p.R323*	C	C		7	Cancer Module	2	33468797	33468797	363	0.347107438016529	NA	NA	NA		p.R649*(1)	108			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33468797,C,C&fts=all">p.R323*</a>
MGAM	Missense_Mutation	p.T2503P	A	A		7	Cancer Module	7	141795413	141795413	579	0.0155440414507772	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141795413,A,A&fts=all">p.T2503P</a>
MTBP	Missense_Mutation	p.P594S	C	C		7	Cancer Module	8	121518998	121518998	220	0.322727272727273	NA	NA	NA			30	Interaction with MDM2. {ECO:0000250}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121518998,C,C&fts=all">p.P594S</a>
MUC16	Missense_Mutation	p.W12945L	C	C		7	Cancer Module	19	9011399	9011399	516	0.162790697674419	NA	NA	NA			590	SEA 6. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9011399,C,C&fts=all">p.W12945L</a>
MUC16	Missense_Mutation	p.S11882F	G	G		7	Cancer Module	19	9045986	9045986	342	0.301169590643275	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9045986,G,G&fts=all">p.S11882F</a>
MUC16	Missense_Mutation	p.S6929F	G	G		7	Cancer Module	19	9066660	9066660	622	0.32475884244373	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9066660,G,G&fts=all">p.S6929F</a>
MUC16	Missense_Mutation	p.E3090K	C	C		7	Cancer Module	19	9082547	9082547	517	0.30174081237911	NA	NA	NA			590	Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9082547,C,C&fts=all">p.E3090K</a>
MUC16	Missense_Mutation	p.S3033G	T	T		7	Cancer Module	19	9082718	9082718	178	0.0224719101123595	NA	NA	NA		p.S3033C(2)	590	Ser-rich.|Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9082718,T,T&fts=all">p.S3033G</a>
MUC16	Missense_Mutation	p.S2327F	G	G		7	Cancer Module	19	9084835	9084835	99	0.303030303030303	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9084835,G,G&fts=all">p.S2327F</a>
NCAN	Missense_Mutation	p.P754L	C	C		7	Cancer Module	19	19338690	19338690	271	0.284132841328413	NA	NA	NA		p.P754L(1)|p.P768L(1)	64			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19338690,C,C&fts=all">p.P754L</a>
NFRKB	Missense_Mutation	p.R1059C	G	G		7	Cancer Module	11	129739745	129739745	109	0.311926605504587	NA	NA	NA			32			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFRKB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,129739745,G,G&fts=all">p.R1059C</a>
NFYC	Nonsense_Mutation	p.Q110*	C	C		7	Cancer Module	1	41218859	41218859	175	0.314285714285714	NA	NA	NA			15			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFYC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,41218859,C,C&fts=all">p.Q110*</a>
NMU	Missense_Mutation	p.G45E	C	C		7	Cancer Module	4	56496606	56496606	455	0.345054945054945	NA	NA	NA			5			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,56496606,C,C&fts=all">p.G45E</a>
NUP210L	Missense_Mutation	p.H1540Y	G	G		7	Cancer Module	1	153991444	153991444	383	0.242819843342037	NA	NA	NA			80			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP210L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,153991444,G,G&fts=all">p.H1540Y</a>
PCLO	Missense_Mutation	p.S4527R	A	A		7	Cancer Module	7	82508726	82508726	128	0.2265625	NA	NA	NA			259			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82508726,A,A&fts=all">p.S4527R</a>
PEX14	Missense_Mutation	p.D354E	T	T		7	Cancer Module	1	10689972	10689972	103	0.427184466019417	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,10689972,T,T&fts=all">p.D354E</a>
PIK3IP1	Splice_Site	p.E103K	C	C		7	Cancer Module	22	31686951	31686951	40	0.55	NA	NA	NA			4			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3IP1&recr=Open">Click here</a>	
PKD1	Missense_Mutation	p.D2821E	G	G		7	Cancer Module	16	2153595	2153595	165	0.321212121212121	NA	NA	NA			72	REJ. {ECO:0000255|PROSITE- ProRule:PRU00511}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,2153595,G,G&fts=all">p.D2821E</a>
PLCB2	Missense_Mutation	p.T100M	G	G		7	Cancer Module	15	40594743	40594743	266	0.018796992481203	NA	NA	NA			39			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40594743,G,G&fts=all">p.T100M</a>
PPP4R1	Missense_Mutation	p.S280L	G	G		7	Cancer Module	18	9583194	9583194	239	0.284518828451883	NA	NA	NA			3			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP4R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,9583194,G,G&fts=all">p.S280L</a>
PTPRN	Missense_Mutation	p.G692R	C	C		7	Cancer Module	2	220161969	220161969	95	0.347368421052632	NA	NA	NA			65			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220161969,C,C&fts=all">p.G692R</a>
RASGRP3	Missense_Mutation	p.E112K	G	G		7	Cancer Module	2	33745717	33745717	438	0.344748858447489	NA	NA	NA			11	N-terminal Ras-GEF. {ECO:0000255|PROSITE- ProRule:PRU00135}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33745717,G,G&fts=all">p.E112K</a>
RP1	Missense_Mutation	p.P1282S	C	C		7	Cancer Module	8	55540286	55540286	463	0.336933045356371	NA	NA	NA			169			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540286,C,C&fts=all">p.P1282S</a>
RREB1	Missense_Mutation	p.S1077L	C	C	rs558604759	7	Cancer Module	6	7231562	7231562	171	0.385964912280702	NA	NA	NA			58			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RREB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7231562,C,C&fts=all">p.S1077L</a>
RYR1	Missense_Mutation	p.A3298T	G	G	rs544339193	7	Cancer Module	19	39008205	39008205	64	0.34375	NA	NA	NA			285			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39008205,G,G&fts=all">p.A3298T</a>
SCN9A	Missense_Mutation	p.S1099L	G	G	rs145258166	7	Cancer Module	2	167128931	167128931	56	0.214285714285714	NA	NA	NA			108			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167128931,G,G&fts=all">p.S1099L</a>
SERPINB2	Missense_Mutation	p.E271K	G	G		7	Cancer Module	18	61569770	61569770	336	0.294642857142857	NA	NA	NA			32			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,61569770,G,G&fts=all">p.E271K</a>
SH3GL3	Missense_Mutation	p.I244M	A	A		7	Cancer Module	15	84257417	84257417	80	0.3875	NA	NA	NA			30	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.|Interaction with ARC. {ECO:0000250}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3GL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,84257417,A,A&fts=all">p.I244M</a>
SIPA1L3	Missense_Mutation	p.E1066K	G	G		7	Cancer Module	19	38631876	38631876	165	0.327272727272727	NA	NA	NA			59			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38631876,G,G&fts=all">p.E1066K</a>
SLC17A8	Nonsense_Mutation	p.E572*	G	G		7	Cancer Module	12	100813881	100813881	85	0.388235294117647	NA	NA	NA			44			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,100813881,G,G&fts=all">p.E572*</a>
SLIT1	Splice_Site	p.E67K	C	C		7	Cancer Module	10	98924646	98924646	104	0.586538461538462	NA	NA	NA			78			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT1	Splice_Site	p.L66L	C	C		7	Cancer Module	10	98924647	98924647	105	0.580952380952381	NA	NA	NA			78			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT1&recr=Open">Click here</a>	
SLIT2	Missense_Mutation	p.P532S	C	C		7	Cancer Module	4	20530703	20530703	237	0.337552742616034	NA	NA	NA			116	LRRNT 3.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,20530703,C,C&fts=all">p.P532S</a>
SQLE	Splice_Site	p.V511I	G	G		7	Cancer Module	8	126033112	126033112	109	0.348623853211009	NA	NA	NA			14			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SQLE&recr=Open">Click here</a>	
SYCP1	Missense_Mutation	p.E533K	G	G		7	Cancer Module	1	115455721	115455721	499	0.348697394789579	NA	NA	NA			48			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115455721,G,G&fts=all">p.E533K</a>
TLL1	Splice_Site		T	T	rs386681721	7	Cancer Module	4	167012495	167012495	94	0.170212765957447	NA	NA	NA			77			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	
TRAK1	Missense_Mutation	p.S354F	C	C	rs370414753	7	Cancer Module	3	42242402	42242402	258	0.414728682170543	NA	NA	NA			22	HAP1 N-terminal.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,42242402,C,C&fts=all">p.S354F</a>
TRPC4	Missense_Mutation	p.H849Y	G	G		7	Cancer Module	13	38211429	38211429	265	0.433962264150943	NA	NA	NA			83	Binds to ITPR1, ITPR2 and ITPR3.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,38211429,G,G&fts=all">p.H849Y</a>
UGT2B15	Missense_Mutation	p.M444I	C	C		7	Cancer Module	4	69513083	69513083	405	0.34320987654321	NA	NA	NA						MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69513083,C,C&fts=all">p.M444I</a>
VARS	Missense_Mutation	p.S437F	G	G		7	Cancer Module	6	31753060	31753060	112	0.25	NA	NA	NA			30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VARS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31753060,G,G&fts=all">p.S437F</a>
ZFP90	Missense_Mutation	p.H547Y	C	C		7	Cancer Module	16	68598329	68598329	324	0.540123456790123	NA	NA	NA			27			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP90&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68598329,C,C&fts=all">p.H547Y</a>
ZMIZ2	Missense_Mutation	p.T770I	C	C		7	Cancer Module	7	44805829	44805829	136	0.558823529411765	NA	NA	NA			35	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMIZ2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,44805829,C,C&fts=all">p.T770I</a>
ZNF93	Missense_Mutation	p.H531Y	C	C		7	Cancer Module	19	20045355	20045355	216	0.310185185185185	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF93&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,20045355,C,C&fts=all">p.H531Y</a>
MYO3B	Missense_Mutation	p.M132I	G	G		7.75	Cancer Gene	2	171070963	171070963	328	0.353658536585366	NA	NA	NA		p.M132I(1)	59	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,171070963,G,G&fts=all">p.M132I</a>
ABCA13	Missense_Mutation	p.L4689F	C	C		8	Cancer Gene	7	48563857	48563857	89	0.235955056179775	NA	NA	NA			270			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48563857,C,C&fts=all">p.L4689F</a>
ABCA13	Missense_Mutation	p.L4689P	T	T		8	Cancer Gene	7	48563858	48563858	89	0.235955056179775	NA	NA	NA			270			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48563858,T,T&fts=all">p.L4689P</a>
ACAN	Nonsense_Mutation	p.Q101*	C	C		8	Cancer Gene	15	89382124	89382124	280	0.292857142857143	NA	NA	NA			93	G1-A.|Ig-like V-type.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACAN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89382124,C,C&fts=all">p.Q101*</a>
ADAMTS20	Missense_Mutation	p.E1019K	C	C		8	Cancer Gene	12	43826148	43826148	160	0.3	NA	NA	NA			95	TSP type-1 4. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43826148,C,C&fts=all">p.E1019K</a>
AKR1B10	Missense_Mutation	p.G115R	G	G	rs146306673	8	Cancer Gene	7	134216768	134216768	815	0.138650306748466	NA	NA	NA			20			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1B10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,134216768,G,G&fts=all">p.G115R</a>
ANO6	Missense_Mutation	p.V501M	G	G		8	Cancer Gene	12	45795629	45795629	391	0.322250639386189	NA	NA	NA			46			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,45795629,G,G&fts=all">p.V501M</a>
ASTN1	Missense_Mutation	p.E502K	C	C		8	Cancer Gene	1	176983946	176983946	1293	0.389791183294664	NA	NA	NA		p.E502K(1)	153	EGF-like 1.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176983946,C,C&fts=all">p.E502K</a>
ATP6V1G3	Missense_Mutation	p.E15D	T	T		8	Cancer Gene	1	198509736	198509736	369	0.127371273712737	NA	NA	NA			7			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1G3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,198509736,T,T&fts=all">p.E15D</a>
ATRNL1	Missense_Mutation	p.S1147L	C	C		8	Cancer Gene	10	117226706	117226706	156	0.442307692307692	NA	NA	NA			95			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,117226706,C,C&fts=all">p.S1147L</a>
BTBD11	Missense_Mutation	p.M479I	G	G		8	Cancer Gene	12	107937863	107937863	117	0.393162393162393	NA	NA	NA			53			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,107937863,G,G&fts=all">p.M479I</a>
C12orf55	Missense_Mutation	p.R1824Q	G	G	rs558062906	8	Cancer Gene	12	97057618	97057618	239	0.322175732217573	NA	NA	NA		p.R249Q(1)				MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf55&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,97057618,G,G&fts=all">p.R1824Q</a>
C2orf57	Nonsense_Mutation	p.Q79*	C	C		8	Cancer Gene	2	232457897	232457897	231	0.32034632034632	NA	NA	NA			19			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf57&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,232457897,C,C&fts=all">p.Q79*</a>
CACNA1H	Missense_Mutation	p.M800I	G	G		8	Cancer Gene	16	1254407	1254407	120	0.191666666666667	NA	NA	NA			34			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1254407,G,G&fts=all">p.M800I</a>
CACNA1H	Missense_Mutation	p.P2191S	C	C		8	Cancer Gene	16	1270521	1270521	74	0.324324324324324	NA	NA	NA			34			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1270521,C,C&fts=all">p.P2191S</a>
CCDC158	Missense_Mutation	p.G720E	C	C		8	Cancer Gene	4	77278541	77278541	161	0.31055900621118	NA	NA	NA			56			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC158&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,77278541,C,C&fts=all">p.G720E</a>
CDH7	Missense_Mutation	p.R109K	G	G		8	Cancer Gene	18	63477055	63477055	192	0.286458333333333	NA	NA	NA			80	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,63477055,G,G&fts=all">p.R109K</a>
CHST10	Missense_Mutation	p.P127L	G	G		8	Cancer Gene	2	101014417	101014417	214	0.299065420560748	NA	NA	NA			16			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,101014417,G,G&fts=all">p.P127L</a>
CMYA5	Missense_Mutation	p.S1855L	C	C		8	Cancer Gene	5	79030152	79030152	145	0.572413793103448	NA	NA	NA			128			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79030152,C,C&fts=all">p.S1855L</a>
CORO7	Missense_Mutation	p.A832T	C	C		8	Cancer Gene	16	4408068	4408068	116	0.362068965517241	NA	NA	NA			23			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CORO7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,4408068,C,C&fts=all">p.A832T</a>
CYP4V2	Missense_Mutation	p.V94A	T	T		8	Cancer Gene	4	187115720	187115720	256	0.3671875	NA	NA	NA			20			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4V2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187115720,T,T&fts=all">p.V94A</a>
DCDC1	Missense_Mutation	p.P1133A	G	G		8	Cancer Gene	11	30938472	30938472	228	0.307017543859649	NA	NA	NA			31			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,30938472,G,G&fts=all">p.P1133A</a>
DEFB123	Missense_Mutation	p.S15F	C	C		8	Cancer Gene	20	30028545	30028545	896	0.3203125	NA	NA	NA			3			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB123&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,30028545,C,C&fts=all">p.S15F</a>
DENND4A	Missense_Mutation	p.P450S	G	G		8	Cancer Gene	15	66021549	66021549	35	0.485714285714286	NA	NA	NA			51	DENN. {ECO:0000255|PROSITE- ProRule:PRU00304}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,66021549,G,G&fts=all">p.P450S</a>
DHX57	Missense_Mutation	p.R286C	G	G		8	Cancer Gene	2	39088696	39088696	339	0.268436578171091	NA	NA	NA			62			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX57&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,39088696,G,G&fts=all">p.R286C</a>
EPHA6	Missense_Mutation	p.Y363D	T	T		8	Cancer Gene	3	96706810	96706810	113	0.433628318584071	NA	NA	NA			101	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,96706810,T,T&fts=all">p.Y363D</a>
ESYT3	Missense_Mutation	p.E359K	G	G		8	Cancer Gene	3	138183346	138183346	160	0.2875	NA	NA	NA			25	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESYT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,138183346,G,G&fts=all">p.E359K</a>
FAT1	Missense_Mutation	p.F2671I	A	A		8	Cancer Gene	4	187539729	187539729	200	0.31	NA	NA	NA			228	Cadherin 24. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187539729,A,A&fts=all">p.F2671I</a>
FAT3	Missense_Mutation	p.F2276C	T	T		8	Cancer Gene	11	92533456	92533456	244	0.172131147540984	NA	NA	NA			85	Cadherin 20. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92533456,T,T&fts=all">p.F2276C</a>
FAT4	Missense_Mutation	p.S1282F	C	C		8	Cancer Gene	4	126241411	126241411	273	0.311355311355311	NA	NA	NA			355	Cadherin 12. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126241411,C,C&fts=all">p.S1282F</a>
FAT4	Missense_Mutation	p.H2469Y	C	C		8	Cancer Gene	4	126367659	126367659	301	0.285714285714286	NA	NA	NA			355	Cadherin 24. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126367659,C,C&fts=all">p.H2469Y</a>
FAT4	Missense_Mutation	p.S4650L	C	C		8	Cancer Gene	4	126411926	126411926	73	0.328767123287671	NA	NA	NA			355			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126411926,C,C&fts=all">p.S4650L</a>
FREM2	Nonsense_Mutation	p.W1768*	G	G		8	Cancer Gene	13	39338481	39338481	391	0.227621483375959	NA	NA	NA			148	Calx-beta 1.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,39338481,G,G&fts=all">p.W1768*</a>
GADL1	Missense_Mutation	p.G279R	C	C		8	Cancer Gene	3	30880557	30880557	226	0.283185840707965	NA	NA	NA			25			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GADL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,30880557,C,C&fts=all">p.G279R</a>
GIMAP6	Missense_Mutation	p.R164Q	C	C	rs376869789	8	Cancer Gene	7	150325195	150325195	666	0.572072072072072	NA	NA	NA			29	AIG1-type G.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150325195,C,C&fts=all">p.R164Q</a>
GPR111	Missense_Mutation	p.G235R	G	G		8	Cancer Gene	6	47649202	47649202	306	0.294117647058824	NA	NA	NA			29			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR111&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,47649202,G,G&fts=all">p.G235R</a>
GPR125	Missense_Mutation	p.S534L	G	G		8	Cancer Gene	4	22425818	22425818	99	0.343434343434343	NA	NA	NA			56			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR125&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,22425818,G,G&fts=all">p.S534L</a>
GPR142	Missense_Mutation	p.T363I	C	C		8	Cancer Gene	17	72368438	72368438	180	0.327777777777778	NA	NA	NA			35			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR142&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72368438,C,C&fts=all">p.T363I</a>
GSG1	Splice_Site	p.G189S	C	C	rs569643105	8	Cancer Gene	12	13240841	13240841	112	0.375	NA	NA	NA			10			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSG1&recr=Open">Click here</a>	
HOXD12	Missense_Mutation	p.P45L	C	C	rs532659358	8	Cancer Gene	2	176964663	176964663	102	0.42156862745098	NA	NA	NA			10			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,176964663,C,C&fts=all">p.P45L</a>
HS3ST4	Missense_Mutation	p.G393E	G	G		8	Cancer Gene	16	26147376	26147376	59	0.355932203389831	NA	NA	NA			15			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,26147376,G,G&fts=all">p.G393E</a>
IFNA8	Missense_Mutation	p.H81Y	C	C		8	Cancer Gene	9	21409416	21409416	224	0.495535714285714	NA	NA	NA			9			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21409416,C,C&fts=all">p.H81Y</a>
KCNK16	Nonsense_Mutation	p.W157*	C	C		8	Cancer Gene	6	39285586	39285586	27	0.333333333333333	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39285586,C,C&fts=all">p.W157*</a>
KCNK16	Nonsense_Mutation	p.W157*	C	C		8	Cancer Gene	6	39285587	39285587	27	0.333333333333333	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,39285587,C,C&fts=all">p.W157*</a>
KHDRBS2	Missense_Mutation	p.G225E	C	C		8	Cancer Gene	6	62604676	62604676	58	0.362068965517241	NA	NA	NA			49	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHDRBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,62604676,C,C&fts=all">p.G225E</a>
KIAA2022	Missense_Mutation	p.G1441R	C	C		8	Cancer Gene	X	73960071	73960071	171	0.649122807017544	NA	NA	NA		p.G1441R(1)	109			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA2022&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,73960071,C,C&fts=all">p.G1441R</a>
KLHL36	Missense_Mutation	p.S394F	C	C		8	Cancer Gene	16	84693409	84693409	250	0.548	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,84693409,C,C&fts=all">p.S394F</a>
LIPI	Missense_Mutation	p.L341F	G	G		8	Cancer Gene	21	15535788	15535788	374	0.29144385026738	NA	NA	NA			54			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIPI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15535788,G,G&fts=all">p.L341F</a>
LPO	Missense_Mutation	p.E335K	G	G		8	Cancer Gene	17	56329765	56329765	101	0.386138613861386	NA	NA	NA			30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56329765,G,G&fts=all">p.E335K</a>
MICALL2	Missense_Mutation	p.P511S	G	G	rs146347352	8	Cancer Gene	7	1482008	1482008	427	0.238875878220141	NA	NA	NA			19	Mediates targeting to the cell plasma membrane. {ECO:0000250}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICALL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,1482008,G,G&fts=all">p.P511S</a>
MITD1	Missense_Mutation	p.R108C	G	G	rs570556878	8	Cancer Gene	2	99788041	99788041	466	0.0107296137339056	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MITD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,99788041,G,G&fts=all">p.R108C</a>
MLIP	Missense_Mutation	p.L20Q	T	T		8	Cancer Gene	6	53883885	53883885	206	0.0242718446601942	NA	NA	NA			34	Interaction with LMNA.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,53883885,T,T&fts=all">p.L20Q</a>
MORC1	Missense_Mutation	p.P176L	G	G		8	Cancer Gene	3	108813812	108813812	367	0.35149863760218	NA	NA	NA			105			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108813812,G,G&fts=all">p.P176L</a>
MPHOSPH9	Missense_Mutation	p.A467V	G	G		8	Cancer Gene	12	123687552	123687552	323	0.0154798761609907	NA	NA	NA			33			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPHOSPH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,123687552,G,G&fts=all">p.A467V</a>
MYOCD	Missense_Mutation	p.D918N	G	G		8	Cancer Gene	17	12666896	12666896	115	0.31304347826087	NA	NA	NA			70			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,12666896,G,G&fts=all">p.D918N</a>
NDST4	Missense_Mutation	p.E632K	C	C		8	Cancer Gene	4	115769417	115769417	213	0.328638497652582	NA	NA	NA			81	Heparan sulfate N-sulfotransferase 4.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDST4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115769417,C,C&fts=all">p.E632K</a>
NEUROD4	Missense_Mutation	p.E30K	G	G		8	Cancer Gene	12	55420311	55420311	155	0.316129032258064	NA	NA	NA			41			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEUROD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55420311,G,G&fts=all">p.E30K</a>
NINL	Missense_Mutation	p.S1326F	G	G		8	Cancer Gene	20	25434259	25434259	167	0.305389221556886	NA	NA	NA			57			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NINL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,25434259,G,G&fts=all">p.S1326F</a>
NLRP4	Missense_Mutation	p.E797K	G	G	rs548667642	8	Cancer Gene	19	56382227	56382227	171	0.35672514619883	NA	NA	NA			42			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56382227,G,G&fts=all">p.E797K</a>
NUDT7	Missense_Mutation	p.A67T	G	G		8	Cancer Gene	16	77769734	77769734	667	0.184407796101949	NA	NA	NA			18	Nudix hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00794}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUDT7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,77769734,G,G&fts=all">p.A67T</a>
OCRL	Missense_Mutation	p.R85W	C	C		8	Cancer Gene	X	128691316	128691316	68	0.75	NA	NA	NA			48	PH.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OCRL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,128691316,C,C&fts=all">p.R85W</a>
OR2M5	Missense_Mutation	p.R220Q	G	G	rs148081072	8	Cancer Gene	1	248309108	248309108	1045	0.304306220095694	NA	NA	NA			49			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2M5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,248309108,G,G&fts=all">p.R220Q</a>
OR4C6	Missense_Mutation	p.L42P	T	T		8	Cancer Gene	11	55432767	55432767	434	0.331797235023041	NA	NA	NA			71			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55432767,T,T&fts=all">p.L42P</a>
OR52B4	Missense_Mutation	p.G201V	C	C		8	Cancer Gene	11	4388924	4388924	136	0.360294117647059	NA	NA	NA			31			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52B4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4388924,C,C&fts=all">p.G201V</a>
OR6C65	Missense_Mutation	p.D17N	G	G		8	Cancer Gene	12	55794361	55794361	143	0.223776223776224	NA	NA	NA			15			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C65&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55794361,G,G&fts=all">p.D17N</a>
OR9K2	Missense_Mutation	p.A198V	C	C		8	Cancer Gene	12	55524145	55524145	360	0.261111111111111	NA	NA	NA			31			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9K2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55524145,C,C&fts=all">p.A198V</a>
OSBP2	Missense_Mutation	p.R533Q	G	G		8	Cancer Gene	22	31285598	31285598	168	0.517857142857143	NA	NA	NA			19			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,31285598,G,G&fts=all">p.R533Q</a>
PABPC1L	Missense_Mutation	p.S341F	C	C		8	Cancer Gene	20	43559150	43559150	593	0.347386172006745	NA	NA	NA			20	RRM 4. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PABPC1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,43559150,C,C&fts=all">p.S341F</a>
PALM2-AKAP2	Frame_Shift_Del	p.P476fs	C	C	rs370739252	8	Cancer Gene	9	112899247	112899247	73	0.424657534246575	NA	NA	NA			44			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALM2-AKAP2&recr=Open">Click here</a>	
PATE2	Missense_Mutation	p.H103Y	G	G		8	Cancer Gene	11	125647312	125647312	169	0.319526627218935	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PATE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,125647312,G,G&fts=all">p.H103Y</a>
PCDHA13	Missense_Mutation	p.P774L	C	C		8	Cancer Gene	5	140264174	140264174	48	0.333333333333333	NA	NA	NA			95	6 X 4 AA repeats of P-X-X-P.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140264174,C,C&fts=all">p.P774L</a>
PCSK9	Missense_Mutation	p.E84K	G	G		8	Cancer Gene	1	55509558	55509558	99	0.313131313131313	NA	NA	NA			32			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,55509558,G,G&fts=all">p.E84K</a>
PPRC1	Missense_Mutation	p.P966S	C	C		8	Cancer Gene	10	103901161	103901161	96	0.479166666666667	NA	NA	NA			56	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPRC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,103901161,C,C&fts=all">p.P966S</a>
ROBO2	Missense_Mutation	p.R18G	C	C		8	Cancer Gene	3	77089988	77089988	397	0.342569269521411	NA	NA	NA			117			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,77089988,C,C&fts=all">p.R18G</a>
RPTN	Missense_Mutation	p.H366Y	G	G		8	Cancer Gene	1	152128479	152128479	2151	0.488609948860995	NA	NA	NA			59	Gln-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152128479,G,G&fts=all">p.H366Y</a>
RUFY3	Missense_Mutation	p.L123F	C	C		8	Cancer Gene	4	71629283	71629283	221	0.357466063348416	NA	NA	NA			16	RUN. {ECO:0000255|PROSITE- ProRule:PRU00178}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUFY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71629283,C,C&fts=all">p.L123F</a>
SEMA4C	Missense_Mutation	p.P828L	G	G		8	Cancer Gene	2	97526382	97526382	141	0.26241134751773	NA	NA	NA			17			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,97526382,G,G&fts=all">p.P828L</a>
SHANK2	Missense_Mutation	p.G563S	C	C		8	Cancer Gene	11	70332923	70332923	153	0.300653594771242	NA	NA	NA			62			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,70332923,C,C&fts=all">p.G563S</a>
SLC35F5	Missense_Mutation	p.H209D	G	G		8	Cancer Gene	2	114500394	114500394	345	0.344927536231884	NA	NA	NA			20			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35F5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,114500394,G,G&fts=all">p.H209D</a>
SPAG17	Missense_Mutation	p.E875K	C	C		8	Cancer Gene	1	118598455	118598455	408	0.343137254901961	NA	NA	NA			123			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,118598455,C,C&fts=all">p.E875K</a>
ST8SIA3	Missense_Mutation	p.G320R	G	G		8	Cancer Gene	18	55027323	55027323	259	0.28957528957529	NA	NA	NA			36			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST8SIA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,55027323,G,G&fts=all">p.G320R</a>
STAB2	Missense_Mutation	p.S576F	C	C		8	Cancer Gene	12	104049352	104049352	192	0.369791666666667	NA	NA	NA			174			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104049352,C,C&fts=all">p.S576F</a>
STARD13	Missense_Mutation	p.D741N	C	C		8	Cancer Gene	13	33692262	33692262	255	0.470588235294118	NA	NA	NA			40	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33692262,C,C&fts=all">p.D741N</a>
THEMIS	Missense_Mutation	p.G353E	C	C		8	Cancer Gene	6	128134491	128134491	281	0.316725978647687	NA	NA	NA			60	CABIT 2.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THEMIS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,128134491,C,C&fts=all">p.G353E</a>
TNRC6A	Missense_Mutation	p.S861L	C	C		8	Cancer Gene	16	24802545	24802545	170	0.288235294117647	NA	NA	NA			64	Interaction with argonaute family proteins.|Sufficient for interaction with AGO1 and AGO4.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24802545,C,C&fts=all">p.S861L</a>
TNRC6B	Nonsense_Mutation	p.W682*	G	G		8	Cancer Gene	22	40708530	40708530	285	0.2	NA	NA	NA			1	Interaction with argonaute proteins.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNRC6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,40708530,G,G&fts=all">p.W682*</a>
TRHR	Missense_Mutation	p.N110I	A	A		8	Cancer Gene	8	110100070	110100070	399	0.343358395989975	NA	NA	NA			37			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110100070,A,A&fts=all">p.N110I</a>
TTLL6	Missense_Mutation	p.R563K	C	C		8	Cancer Gene	17	46863599	46863599	1033	0.318489835430784	NA	NA	NA			18			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,46863599,C,C&fts=all">p.R563K</a>
ZAP70	Missense_Mutation	p.P268S	C	C		8	Cancer Gene	2	98349771	98349771	53	0.30188679245283	NA	NA	NA			29	Interdomain B.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAP70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,98349771,C,C&fts=all">p.P268S</a>
ZBBX	Missense_Mutation	p.E743K	C	C		8	Cancer Gene	3	167000053	167000053	156	0.314102564102564	NA	NA	NA			70			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBBX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,167000053,C,C&fts=all">p.E743K</a>
ZNF420	Missense_Mutation	p.L630F	C	C		8	Cancer Gene	19	37619781	37619781	158	0.354430379746835	NA	NA	NA			27			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF420&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37619781,C,C&fts=all">p.L630F</a>
ZNF645	Missense_Mutation	p.R142Q	G	G		8	Cancer Gene	X	22291533	22291533	148	0.702702702702703	NA	NA	NA			27	HYB domain.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF645&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,22291533,G,G&fts=all">p.R142Q</a>
ZNF721	Missense_Mutation	p.R422G	G	G	rs539113119|rs200194061	8	Cancer Gene	4	436992	436992	196	0.26530612244898	NA	NA	NA			33			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF721&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,436992,G,G&fts=all">p.R422G</a>
ZNF804A	Missense_Mutation	p.E559K	G	G		8	Cancer Gene	2	185801798	185801798	133	0.278195488721804	NA	NA	NA			146			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185801798,G,G&fts=all">p.E559K</a>
ZNF831	Missense_Mutation	p.A329V	C	C	rs568542313	8	Cancer Gene	20	57767060	57767060	54	0.37037037037037	NA	NA	NA			125			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF831&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,57767060,C,C&fts=all">p.A329V</a>
ETNPPL	Missense_Mutation	p.G237E	C	C		10	SNP	4	109670491	109670491	291	0.347079037800687	NA	NA	NA						MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETNPPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,109670491,C,C&fts=all">p.G237E</a>
NUGGC	Missense_Mutation	p.G740E	C	C		10	SNP	8	27884505	27884505	326	0.322085889570552	NA	NA	NA						MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUGGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27884505,C,C&fts=all">p.G740E</a>
NYAP1	Missense_Mutation	p.E365K	G	G		10	SNP	7	100086437	100086437	142	0.5	NA	NA	NA				Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NYAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100086437,G,G&fts=all">p.E365K</a>
STPG2	Missense_Mutation	p.R192Q	C	C	rs147933911	10	SNP	4	99027141	99027141	87	0.252873563218391	NA	NA	NA						MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STPG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,99027141,C,C&fts=all">p.R192Q</a>
TEX33	Nonsense_Mutation	p.Q114*	G	G		10	SNP	22	37398027	37398027	90	0.2	NA	NA	NA						MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX33&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37398027,G,G&fts=all">p.Q114*</a>
ABCF3	5'UTR		-	-		11	Filtered Calls	3	183903940	183903941	34	0.5	NA	NA	NA			39			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCF3&recr=Open">Click here</a>	
AC002310.13	Intron		G	G		11	Filtered Calls	16	30567178	30567178	69	0.318840579710145	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC002310.13&recr=Open">Click here</a>	
ACSM4	Intron		A	A		11	Filtered Calls	12	7475140	7475140	99	0.292929292929293	NA	NA	NA			21			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM4&recr=Open">Click here</a>	
AHNAK	5'Flank		G	G		11	Filtered Calls	11	62286571	62286571	238	0.0420168067226891	NA	NA	NA			268			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK&recr=Open">Click here</a>	
AHNAK2	Intron		G	G		11	Filtered Calls	14	105412740	105412740	648	0.341049382716049	NA	NA	NA			33			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK2&recr=Open">Click here</a>	
AKAP6	Silent	p.D1159D	C	C		11	Filtered Calls	14	33242988	33242988	239	0.326359832635983	NA	NA	NA			122			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP6&recr=Open">Click here</a>	
ALDH16A1	Silent	p.S204S	C	C		11	Filtered Calls	19	49964910	49964910	28	0.464285714285714	NA	NA	NA			20			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH16A1&recr=Open">Click here</a>	
ALPI	Intron		C	C		11	Filtered Calls	2	233321599	233321599	76	0.434210526315789	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPI&recr=Open">Click here</a>	
ALPP	Silent	p.S192S	G	G		11	Filtered Calls	2	233244565	233244565	155	0.380645161290323	NA	NA	NA			22			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPP&recr=Open">Click here</a>	
ANKRD50	Silent	p.S566S	A	A		11	Filtered Calls	4	125592734	125592734	281	0.341637010676157	NA	NA	NA			55			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD50&recr=Open">Click here</a>	
ASTN1	Intron		G	G		11	Filtered Calls	1	176833600	176833600	120	0.291666666666667	NA	NA	NA			153			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	
ATP6V1E2	Silent	p.A23A	G	G		11	Filtered Calls	2	46739782	46739782	283	0.360424028268551	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V1E2&recr=Open">Click here</a>	
BCL9L	5'UTR		G	G		11	Filtered Calls	11	118773151	118773151	73	0.356164383561644	NA	NA	NA			56			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
C11orf54	Intron		T	T		11	Filtered Calls	11	93483506	93483506	263	0.32319391634981	NA	NA	NA			8			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf54&recr=Open">Click here</a>	
C15orf26	Silent	p.P210P	C	C		11	Filtered Calls	15	81436155	81436155	179	0.0223463687150838	NA	NA	NA			17			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf26&recr=Open">Click here</a>	
C20orf195	3'UTR		G	G		11	Filtered Calls	20	62187979	62187979	284	0.334507042253521	NA	NA	NA			7			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf195&recr=Open">Click here</a>	
C3orf38	Intron		C	C		11	Filtered Calls	3	88205268	88205268	267	0.367041198501873	NA	NA	NA			12			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf38&recr=Open">Click here</a>	
CAMK1D	Intron		G	G		11	Filtered Calls	10	12858332	12858332	64	0.546875	NA	NA	NA			16			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1D&recr=Open">Click here</a>	
CAPS2	Silent	p.A293A	G	G		11	Filtered Calls	12	75676125	75676125	571	0.273204903677758	NA	NA	NA			10			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPS2&recr=Open">Click here</a>	
CERS4	Intron		C	C		11	Filtered Calls	19	8322862	8322862	240	0.308333333333333	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CERS4&recr=Open">Click here</a>	
CHD7	Silent	p.L1344L	C	C		11	Filtered Calls	8	61749418	61749418	395	0.291139240506329	NA	NA	NA		p.L1344L(2)	123	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD7&recr=Open">Click here</a>	
CHIT1	Silent	p.L24L	C	C		11	Filtered Calls	1	203194982	203194982	65	0.353846153846154	NA	NA	NA			27			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIT1&recr=Open">Click here</a>	
CHML	Silent	p.G569G	G	G		11	Filtered Calls	1	241797362	241797362	133	0.338345864661654	NA	NA	NA			26			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHML&recr=Open">Click here</a>	
CLEC4E	Silent	p.F38F	G	G		11	Filtered Calls	12	8692467	8692467	877	0.315849486887115	NA	NA	NA			12			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4E&recr=Open">Click here</a>	
CMPK2	Silent	p.K393K	C	C		11	Filtered Calls	2	6991628	6991628	117	0.35042735042735	NA	NA	NA			16			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMPK2&recr=Open">Click here</a>	
CNTNAP2	Silent	p.G1161G	G	G		11	Filtered Calls	7	148080748	148080748	377	0.618037135278515	NA	NA	NA			188	Laminin G-like 4. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	
COL7A1	Intron		G	G		11	Filtered Calls	3	48615805	48615805	173	0.289017341040462	NA	NA	NA			137			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL7A1&recr=Open">Click here</a>	
CRB1	Intron		C	C		11	Filtered Calls	1	197297545	197297545	140	0.278571428571429	NA	NA	NA		p.?(2)	132			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRB1&recr=Open">Click here</a>	
CTNND1	Intron		C	C		11	Filtered Calls	11	57573348	57573348	82	0.268292682926829	NA	NA	NA			45			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND1&recr=Open">Click here</a>	
DAPP1	Intron		C	C		11	Filtered Calls	4	100774368	100774368	104	0.211538461538462	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAPP1&recr=Open">Click here</a>	
DCAF13	Intron		C	C		11	Filtered Calls	8	104438280	104438280	104	0.298076923076923	NA	NA	NA			25			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF13&recr=Open">Click here</a>	
DDX56	Intron		G	G		11	Filtered Calls	7	44610395	44610395	389	0.498714652956298	NA	NA	NA			16			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX56&recr=Open">Click here</a>	
DNAAF1	Silent	p.V427V	G	G		11	Filtered Calls	16	84203715	84203715	208	0.158653846153846	NA	NA	NA			41	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAAF1&recr=Open">Click here</a>	
DNAH11	Silent	p.F1261F	C	C		11	Filtered Calls	7	21646282	21646282	84	0.202380952380952	NA	NA	NA			230	Stem. {ECO:0000250}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	
DNAH11	Intron		C	C		11	Filtered Calls	7	21893923	21893923	106	0.207547169811321	NA	NA	NA			230			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	
DNAH17	Intron		G	G		11	Filtered Calls	17	76566320	76566320	20	0.5	NA	NA	NA			116			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	
DNASE2B	Silent	p.S243S	G	G		11	Filtered Calls	1	84878213	84878213	298	0.359060402684564	NA	NA	NA			6			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNASE2B&recr=Open">Click here</a>	
DNMT1	Intron		G	G		11	Filtered Calls	19	10286208	10286208	185	0.351351351351351	NA	NA	NA			70			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMT1&recr=Open">Click here</a>	
DPP10	Intron		T	T		11	Filtered Calls	2	116447407	116447407	164	0.384146341463415	NA	NA	NA			101			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPP10&recr=Open">Click here</a>	
EEF2	Intron		G	G		11	Filtered Calls	19	3979441	3979441	190	0.378947368421053	NA	NA	NA			21			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EEF2&recr=Open">Click here</a>	
EFCAB12	Silent	p.R553R	C	C		11	Filtered Calls	3	129120496	129120496	38	0.263157894736842	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB12&recr=Open">Click here</a>	
EMCN	Intron		T	T		11	Filtered Calls	4	101338270	101338270	279	0.103942652329749	NA	NA	NA			13			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMCN&recr=Open">Click here</a>	
ENPP3	Silent	p.R298R	G	G		11	Filtered Calls	6	131997897	131997897	237	0.324894514767932	NA	NA	NA			53	Phosphodiesterase.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP3&recr=Open">Click here</a>	
EPPIN-WFDC6	Silent	p.A17A	C	C	rs140030357	11	Filtered Calls	20	44175946	44175946	203	0.285714285714286	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPPIN-WFDC6&recr=Open">Click here</a>	
ERCC3	Silent	p.K449K	C	C		11	Filtered Calls	2	128038203	128038203	161	0.360248447204969	NA	NA	NA			31	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC3&recr=Open">Click here</a>	
ESPL1	Intron		C	C		11	Filtered Calls	12	53682493	53682493	138	0.0289855072463768	NA	NA	NA			70			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESPL1&recr=Open">Click here</a>	
ESR2	Silent	p.V91V	G	G		11	Filtered Calls	14	64749431	64749431	211	0.388625592417062	NA	NA	NA			23	Modulating.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESR2&recr=Open">Click here</a>	
ESYT3	Silent	p.F140F	C	C		11	Filtered Calls	3	138174086	138174086	288	0.347222222222222	NA	NA	NA			25	Glycerophospholipid-binding barrel-like domain. {ECO:0000250}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESYT3&recr=Open">Click here</a>	
FAM135A	Intron		T	T		11	Filtered Calls	6	71235250	71235250	184	0.298913043478261	NA	NA	NA			38			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135A&recr=Open">Click here</a>	
FER1L6	Silent	p.Q350Q	G	G		11	Filtered Calls	8	124989836	124989836	121	0.363636363636364	NA	NA	NA			118			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FER1L6&recr=Open">Click here</a>	
FLNB	Intron		G	G	rs201871482	11	Filtered Calls	3	58135961	58135961	290	0.0172413793103448	NA	NA	NA		p.?(2)	120			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNB&recr=Open">Click here</a>	
FREM1	Intron		C	C		11	Filtered Calls	9	14775778	14775778	50	0.52	NA	NA	NA			100			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	
GPRC6A	Silent	p.A421A	G	G		11	Filtered Calls	6	117127605	117127605	154	0.318181818181818	NA	NA	NA			65			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC6A&recr=Open">Click here</a>	
GRIN2A	Silent	p.V1031V	G	G		11	Filtered Calls	16	9858308	9858308	294	0.336734693877551	NA	NA	NA			198			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2A&recr=Open">Click here</a>	
GRIN2C	Silent	p.T278T	G	G		11	Filtered Calls	17	72848316	72848316	8	0.375	NA	NA	NA			33			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2C&recr=Open">Click here</a>	
GRM8	Silent	p.I757I	G	G		11	Filtered Calls	7	126173165	126173165	165	0.212121212121212	NA	NA	NA			125			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM8&recr=Open">Click here</a>	
GSDMA	Silent	p.T369T	G	G	rs201198563	11	Filtered Calls	17	38133080	38133080	340	0.347058823529412	NA	NA	NA			7			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMA&recr=Open">Click here</a>	
GTSE1	Intron		C	C		11	Filtered Calls	22	46704848	46704848	83	0.457831325301205	NA	NA	NA			27			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTSE1&recr=Open">Click here</a>	
HELLS	Silent	p.I590I	C	C	rs147829794	11	Filtered Calls	10	96351988	96351988	125	0.512	NA	NA	NA			22			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HELLS&recr=Open">Click here</a>	
HK3	Silent	p.I796I	G	G		11	Filtered Calls	5	176308698	176308698	367	0.465940054495913	NA	NA	NA			47	Catalytic.|Hexokinase type-2 2.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HK3&recr=Open">Click here</a>	
HLA-DRA	Intron		C	C	rs371727409|rs58547911	11	Filtered Calls	6	32411525	32411525	507	0.264299802761341	NA	NA	NA			19			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DRA&recr=Open">Click here</a>	
HSPA14	Silent	p.A85A	G	G	rs550196167	11	Filtered Calls	10	14890641	14890641	129	0.449612403100775	NA	NA	NA			17			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA14&recr=Open">Click here</a>	
IFIT3	Silent	p.R75R	G	G		11	Filtered Calls	10	91098637	91098637	179	0.0223463687150838	NA	NA	NA			15			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFIT3&recr=Open">Click here</a>	
IGHV6-1	RNA		G	G		11	Filtered Calls	14	106406045	106406045	83	0.216867469879518	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV6-1&recr=Open">Click here</a>	
IL1B	Intron		A	A		11	Filtered Calls	2	113590946	113590946	101	0.336633663366337	NA	NA	NA			12			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1B&recr=Open">Click here</a>	
IL7R	Silent	p.I271I	C	C	rs200468194	11	Filtered Calls	5	35875626	35875626	127	0.433070866141732	NA	NA	NA			126			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL7R&recr=Open">Click here</a>	
INF2	IGR		G	G		11	Filtered Calls	14	105181082	105181082	42	0.357142857142857	NA	NA	NA			8			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INF2&recr=Open">Click here</a>	
IPO7	Intron		T	T		11	Filtered Calls	11	9466632	9466632	215	0.26046511627907	NA	NA	NA			29			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO7&recr=Open">Click here</a>	
JMJD7-PLA2G4B	3'UTR		C	C		11	Filtered Calls	15	42140051	42140051	54	0.296296296296296	NA	NA	NA			25			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JMJD7-PLA2G4B&recr=Open">Click here</a>	
KCNK1	Silent	p.V282V	G	G		11	Filtered Calls	1	233807111	233807111	192	0.359375	NA	NA	NA			11			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK1&recr=Open">Click here</a>	
KCNQ5	Intron		G	G		11	Filtered Calls	6	73751649	73751649	543	0.318600368324125	NA	NA	NA			57			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ5&recr=Open">Click here</a>	
KIAA0100	Silent	p.F1182F	G	G		11	Filtered Calls	17	26960339	26960339	348	0.318965517241379	NA	NA	NA			68			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0100&recr=Open">Click here</a>	
KRT37	Silent	p.R271R	C	C		11	Filtered Calls	17	39578606	39578606	349	0.292263610315186	NA	NA	NA			25	Coil 2.|Rod.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT37&recr=Open">Click here</a>	
LALBA	Silent	p.I74I	G	G		11	Filtered Calls	12	48962935	48962935	178	0.314606741573034	NA	NA	NA			3			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LALBA&recr=Open">Click here</a>	
LBH	3'UTR		G	G		11	Filtered Calls	2	30480434	30480434	140	0.35	NA	NA	NA			5			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LBH&recr=Open">Click here</a>	
LILRA2	5'UTR		G	G		11	Filtered Calls	19	55085334	55085334	201	0.278606965174129	NA	NA	NA			50			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	
LY9	Intron		G	G		11	Filtered Calls	1	160771702	160771702	202	0.351485148514851	NA	NA	NA			36			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY9&recr=Open">Click here</a>	
MAN2B1	Intron		G	G		11	Filtered Calls	19	12767377	12767377	171	0.0292397660818713	NA	NA	NA			33			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAN2B1&recr=Open">Click here</a>	
MAPK8IP3	Intron		C	C		11	Filtered Calls	16	1779583	1779583	20	0.15	NA	NA	NA			42			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK8IP3&recr=Open">Click here</a>	
MATN2	Intron		C	C		11	Filtered Calls	8	98991110	98991110	170	0.294117647058824	NA	NA	NA			31			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MATN2&recr=Open">Click here</a>	
MFSD6	Silent	p.E744E	G	G		11	Filtered Calls	2	191364800	191364800	163	0.398773006134969	NA	NA	NA			23			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD6&recr=Open">Click here</a>	
MMP12	RNA		G	G		11	Filtered Calls	11	102738092	102738092	50	0.2	NA	NA	NA			26			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP12&recr=Open">Click here</a>	
MUC16	Intron		G	G		11	Filtered Calls	19	8979213	8979213	160	0.2625	NA	NA	NA			590			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC16	Silent	p.S9339S	G	G		11	Filtered Calls	19	9059429	9059429	307	0.384364820846906	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC5AC	3'UTR		G	G		11	Filtered Calls	11	1216368	1216368	64	0.234375	NA	NA	NA			203			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC5AC&recr=Open">Click here</a>	
MYD88	Silent	p.D165D	C	C		11	Filtered Calls	3	38181482	38181482	52	0.25	NA	NA	NA			237	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYD88&recr=Open">Click here</a>	
MYH4	Silent	p.R1703R	C	C		11	Filtered Calls	17	10350390	10350390	231	0.220779220779221	NA	NA	NA			149			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	
NDN	Silent	p.G229G	C	C		11	Filtered Calls	15	23931678	23931678	96	0.354166666666667	NA	NA	NA			39	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDN&recr=Open">Click here</a>	
NEFL	RNA		G	G		11	Filtered Calls	8	24811234	24811234	159	0.352201257861635	NA	NA	NA			21			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFL&recr=Open">Click here</a>	
NEURL3	RNA		G	G		11	Filtered Calls	2	97166402	97166402	9	0.555555555555556	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEURL3&recr=Open">Click here</a>	
NGDN	Intron		C	C		11	Filtered Calls	14	23947204	23947204	554	0.297833935018051	NA	NA	NA			12			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NGDN&recr=Open">Click here</a>	
NLRP9	5'UTR		C	C	rs370767891	11	Filtered Calls	19	56249743	56249743	311	0.318327974276527	NA	NA	NA			74			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	
NPNT	Silent	p.N147N	C	C	rs140313471	11	Filtered Calls	4	106858251	106858251	333	0.291291291291291	NA	NA	NA			21	EGF-like 3. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPNT&recr=Open">Click here</a>	
NWD1	Intron		G	G		11	Filtered Calls	19	16876006	16876006	52	0.384615384615385	NA	NA	NA			67			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NWD1&recr=Open">Click here</a>	
OASL	Silent	p.L427L	C	C		11	Filtered Calls	12	121458628	121458628	178	0.359550561797753	NA	NA	NA			14	Ubiquitin-like 1. {ECO:0000255|PROSITE- ProRule:PRU00214}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OASL&recr=Open">Click here</a>	
OLFML2B	3'UTR		G	G		11	Filtered Calls	1	161953455	161953455	177	0.355932203389831	NA	NA	NA			48			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFML2B&recr=Open">Click here</a>	
OR4A16	Silent	p.S52S	C	C		11	Filtered Calls	11	55110832	55110832	361	0.379501385041551	NA	NA	NA			51			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4A16&recr=Open">Click here</a>	
OR8B12	Silent	p.S263S	G	G		11	Filtered Calls	11	124412762	124412762	198	0.303030303030303	NA	NA	NA			31			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8B12&recr=Open">Click here</a>	
OR8J3	Silent	p.R227R	C	C		11	Filtered Calls	11	55904514	55904514	218	0.348623853211009	NA	NA	NA			59			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8J3&recr=Open">Click here</a>	
OSBP2	Silent	p.R533R	G	G		11	Filtered Calls	22	31285599	31285599	163	0.521472392638037	NA	NA	NA			19			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBP2&recr=Open">Click here</a>	
P4HA2	Silent	p.I113I	G	G	rs34435009	11	Filtered Calls	5	131549739	131549739	94	0.0425531914893617	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P4HA2&recr=Open">Click here</a>	
PADI2	Intron		GGCAG	GGCAG		11	Filtered Calls	1	17422505	17422509	107	0.0373831775700935	NA	NA	NA			29			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PADI2&recr=Open">Click here</a>	
PAMR1	Silent	p.S490S	G	G	rs200076924	11	Filtered Calls	11	35456216	35456216	169	0.0236686390532544	NA	NA	NA			26	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAMR1&recr=Open">Click here</a>	
PCDH1	Silent	p.L127L	G	G		11	Filtered Calls	5	141248656	141248656	83	0.614457831325301	NA	NA	NA			51	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH1&recr=Open">Click here</a>	
PCDHA2	IGR		G	G		11	Filtered Calls	5	140188055	140188055	265	0.532075471698113	NA	NA	NA			71			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHB5	Silent	p.F308F	C	C		11	Filtered Calls	5	140515940	140515940	279	0.519713261648746	NA	NA	NA			81	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB5&recr=Open">Click here</a>	
PEAR1	Intron		G	G		11	Filtered Calls	1	156882177	156882177	163	0.496932515337423	NA	NA	NA			43			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEAR1&recr=Open">Click here</a>	
PEF1	Silent	p.F272F	G	G		11	Filtered Calls	1	32096253	32096253	115	0.278260869565217	NA	NA	NA			7	EF-hand 5. {ECO:0000255|PROSITE- ProRule:PRU00448}.|Required for interaction with PDCD6.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEF1&recr=Open">Click here</a>	
PHF20L1	Intron		C	C		11	Filtered Calls	8	133816055	133816055	55	0.472727272727273	NA	NA	NA			15			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF20L1&recr=Open">Click here</a>	
PLXNB3	Silent	p.P846P	C	C		11	Filtered Calls	X	153037339	153037339	30	0.666666666666667	NA	NA	NA			32	IPT/TIG 1.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNB3&recr=Open">Click here</a>	
PNPLA6	Silent	p.F151F	C	C		11	Filtered Calls	19	7605050	7605050	181	0.364640883977901	NA	NA	NA			35			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA6&recr=Open">Click here</a>	
POLR2A	Intron		C	C		11	Filtered Calls	17	7400665	7400665	103	0.16504854368932	NA	NA	NA			50			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR2A&recr=Open">Click here</a>	
POLR3A	Intron		A	A		11	Filtered Calls	10	79770223	79770223	124	0.443548387096774	NA	NA	NA			59			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3A&recr=Open">Click here</a>	
PSG4	Intron		T	T		11	Filtered Calls	19	43708427	43708427	347	0.31700288184438	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG4&recr=Open">Click here</a>	
PTPRN	Silent	p.T691T	C	C	rs145338513	11	Filtered Calls	2	220161970	220161970	96	0.364583333333333	NA	NA	NA			65			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRN&recr=Open">Click here</a>	
RAB34	Intron		G	G		11	Filtered Calls	17	27042735	27042735	225	0.346666666666667	NA	NA	NA			14			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB34&recr=Open">Click here</a>	
RBM27	Silent	p.P318P	C	C		11	Filtered Calls	5	145613116	145613116	221	0.506787330316742	NA	NA	NA			39	Pro-rich.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM27&recr=Open">Click here</a>	
RFX6	Intron		C	C	rs199809402	11	Filtered Calls	6	117246606	117246606	368	0.3125	NA	NA	NA			59			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	
RGS12	Silent	p.F590F	C	C	rs375660604	11	Filtered Calls	4	3319667	3319667	362	0.345303867403315	NA	NA	NA			43			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS12&recr=Open">Click here</a>	
RP11-1055B8.7	Silent	p.S1357S	C	C		11	Filtered Calls	17	79418788	79418788	50	0.48	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-1055B8.7&recr=Open">Click here</a>	
RP11-58C22.1	Silent	p.S8S	C	C		11	Filtered Calls	16	76587337	76587337	69	0.115942028985507	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-58C22.1&recr=Open">Click here</a>	
RP11-986E7.7	Intron		C	C		11	Filtered Calls	14	95081854	95081854	11	0.363636363636364	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-986E7.7&recr=Open">Click here</a>	
RYR1	Silent	p.L4801L	C	C		11	Filtered Calls	19	39070660	39070660	250	0.336	NA	NA	NA			285			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
SCN3A	Silent	p.T1964T	G	G		11	Filtered Calls	2	165946771	165946771	191	0.382198952879581	NA	NA	NA			120			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	
SERPINA13P	RNA		G	G		11	Filtered Calls	14	95108015	95108015	117	0.316239316239316	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA13P&recr=Open">Click here</a>	
SHB	Silent	p.P199P	G	G		11	Filtered Calls	9	38068046	38068046	7	0.714285714285714	NA	NA	NA			11	Mediates interaction with LAT, PTK2/FAK1, JAK1 and JAK3.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHB&recr=Open">Click here</a>	
SLC22A3	Silent	p.L500L	G	G	rs143468372	11	Filtered Calls	6	160864764	160864764	223	0.345291479820628	NA	NA	NA			27			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC5A12	Silent	p.I241I	G	G		11	Filtered Calls	11	26725176	26725176	388	0.314432989690722	NA	NA	NA			35			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A12&recr=Open">Click here</a>	
SNAP47	5'Flank		G	G		11	Filtered Calls	1	227921686	227921686	100	0.32	NA	NA	NA			17			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP47&recr=Open">Click here</a>	
SORL1	Silent	p.F284F	C	C		11	Filtered Calls	11	121367671	121367671	278	0.341726618705036	NA	NA	NA			91			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	
SORL1	Silent	p.T698T	C	C		11	Filtered Calls	11	121483486	121483486	121	0.330578512396694	NA	NA	NA			91			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	
SPTA1	Silent	p.L1007L	G	G		11	Filtered Calls	1	158624416	158624416	207	0.159420289855072	NA	NA	NA			307	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
STARD13	Silent	p.R740R	C	C		11	Filtered Calls	13	33692263	33692263	256	0.46875	NA	NA	NA			40	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	
SULT1A2	IGR		C	C		11	Filtered Calls	16	28602088	28602088	118	0.322033898305085	NA	NA	NA			14			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1A2&recr=Open">Click here</a>	
SULT1B1	Silent	p.T76T	A	A	rs537653032	11	Filtered Calls	4	70620437	70620437	520	0.0192307692307692	NA	NA	NA			24			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1B1&recr=Open">Click here</a>	
SUN5	Intron		T	T		11	Filtered Calls	20	31590663	31590663	175	0.32	NA	NA	NA			25			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUN5&recr=Open">Click here</a>	
SYNDIG1	Silent	p.E152E	G	G		11	Filtered Calls	20	24524189	24524189	266	0.281954887218045	NA	NA	NA			24	Poly-Glu.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNDIG1&recr=Open">Click here</a>	
SYNE3	Silent	p.I108I	G	G		11	Filtered Calls	14	95932571	95932571	153	0.294117647058824	NA	NA	NA			28			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE3&recr=Open">Click here</a>	
T	Silent	p.E232E	T	T		11	Filtered Calls	6	166578127	166578127	342	0.318713450292398	NA	NA	NA			39			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+T&recr=Open">Click here</a>	
TBL1Y	Silent	p.T123T	C	C		11	Filtered Calls	Y	6932102	6932102	57	0.596491228070175	NA	NA	NA			8			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBL1Y&recr=Open">Click here</a>	
TENM1	Silent	p.G569G	C	C		11	Filtered Calls	X	123779162	123779162	256	0.62109375	NA	NA	NA			NA	EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TPR	Intron		A	A		11	Filtered Calls	1	186303669	186303669	270	0.377777777777778	NA	NA	NA			123			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPR&recr=Open">Click here</a>	
TPTE	Silent	p.L510L	T	T		11	Filtered Calls	21	10907031	10907031	226	0.13716814159292	NA	NA	NA			130	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TPTE	Intron		G	G		11	Filtered Calls	21	10941899	10941899	913	0.0898138006571741	NA	NA	NA		p.?(2)	130			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TRBV5-4	RNA		G	G		11	Filtered Calls	7	142168486	142168486	536	0.169776119402985	NA	NA	NA			NA			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV5-4&recr=Open">Click here</a>	
TRMT11	Silent	p.L429L	C	C		11	Filtered Calls	6	126359890	126359890	408	0.291666666666667	NA	NA	NA			18			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT11&recr=Open">Click here</a>	
TRPM7	Intron		A	A		11	Filtered Calls	15	50885954	50885954	229	0.318777292576419	NA	NA	NA			52			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM7&recr=Open">Click here</a>	
TRPV6	5'UTR		G	G	rs199826925	11	Filtered Calls	7	142583262	142583262	353	0.674220963172805	NA	NA	NA			42			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV6&recr=Open">Click here</a>	
TSSK2	Silent	p.K146K	G	G		11	Filtered Calls	22	19119350	19119350	278	0.52158273381295	NA	NA	NA			11	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSSK2&recr=Open">Click here</a>	
TTC23L	Silent	p.F21F	C	C		11	Filtered Calls	5	34840839	34840839	161	0.291925465838509	NA	NA	NA			22			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC23L&recr=Open">Click here</a>	
UNC45B	Silent	p.F926F	C	C		11	Filtered Calls	17	33513560	33513560	102	0.323529411764706	NA	NA	NA			59			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC45B&recr=Open">Click here</a>	
USP34	Silent	p.L3272L	G	G		11	Filtered Calls	2	61417465	61417465	310	0.348387096774194	NA	NA	NA			138			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP34&recr=Open">Click here</a>	
USP44	Intron		C	C		11	Filtered Calls	12	95922687	95922687	210	0.295238095238095	NA	NA	NA			36			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP44&recr=Open">Click here</a>	
VARS	Silent	p.S437S	G	G		11	Filtered Calls	6	31753059	31753059	113	0.256637168141593	NA	NA	NA			30			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VARS&recr=Open">Click here</a>	
XCR1	Silent	p.G199G	C	C		11	Filtered Calls	3	46062843	46062843	98	0.244897959183673	NA	NA	NA			14			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XCR1&recr=Open">Click here</a>	
ZNF274	3'UTR		C	C		11	Filtered Calls	19	58724284	58724284	142	0.352112676056338	NA	NA	NA			21			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF274&recr=Open">Click here</a>	
ZZEF1	Silent	p.F2904F	G	G	rs190769959	11	Filtered Calls	17	3912919	3912919	113	0.309734513274336	NA	NA	NA			84			MEL-IPI_Pat17-Tumor-SM-4DK1D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZEF1&recr=Open">Click here</a>	
